GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Philogen SpA (STU:78Q) » Definitions » EV-to-FCF

Philogen SpA (STU:78Q) EV-to-FCF : -22.65 (As of Dec. 15, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Philogen SpA EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Philogen SpA's Enterprise Value is €698.69 Mil. Philogen SpA's Free Cash Flow for the trailing twelve months (TTM) ended in Jun. 2024 was €-30.85 Mil. Therefore, Philogen SpA's EV-to-FCF for today is -22.65.

The historical rank and industry rank for Philogen SpA's EV-to-FCF or its related term are showing as below:

STU:78Q' s EV-to-FCF Range Over the Past 10 Years
Min: -76.18   Med: -55.81   Max: -16.65
Current: -22.65

During the past 4 years, the highest EV-to-FCF of Philogen SpA was -16.65. The lowest was -76.18. And the median was -55.81.

STU:78Q's EV-to-FCF is ranked worse than
100% of 392 companies
in the Biotechnology industry
Industry Median: 8.19 vs STU:78Q: -22.65

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2024-12-15), Philogen SpA's stock price is €18.20. Philogen SpA's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2024 was €-0.730. Therefore, Philogen SpA's PE Ratio (TTM) for today is At Loss.


Philogen SpA EV-to-FCF Historical Data

The historical data trend for Philogen SpA's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Philogen SpA EV-to-FCF Chart

Philogen SpA Annual Data
Trend Dec20 Dec21 Dec22 Dec23
EV-to-FCF
- -19.03 -53.98 -63.82

Philogen SpA Semi-Annual Data
Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only - -53.98 - -63.82 -

Competitive Comparison of Philogen SpA's EV-to-FCF

For the Biotechnology subindustry, Philogen SpA's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Philogen SpA's EV-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Philogen SpA's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Philogen SpA's EV-to-FCF falls into.



Philogen SpA EV-to-FCF Calculation

Philogen SpA's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=698.689/-30.852
=-22.65

Philogen SpA's current Enterprise Value is €698.69 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Philogen SpA's Free Cash Flow for the trailing twelve months (TTM) ended in Jun. 2024 was €-30.85 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Philogen SpA  (STU:78Q) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Philogen SpA's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=18.20/-0.730
=At Loss

Philogen SpA's share price for today is €18.20.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Philogen SpA's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2024 was €-0.730.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Philogen SpA EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Philogen SpA's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Philogen SpA Business Description

Traded in Other Exchanges
Address
Piazza La Lizza No. 7, Siena, ITA, 53100
Philogen SpA is a biotechnology company. The company develops biotech products for the imaging and therapy of life-threatening diseases. The company's focus is predominantly related to oncology drug development, although the company has also brought products for the treatment of chronic inflammatory diseases to the clinic. Its pipeline products include Nidlegy; Fibromun; Darleukin; Dodekin; Dekavil and others. Geographically, the company operates in the European Union, Switzerland, and the United States of America.

Philogen SpA Headlines

No Headlines